Kiniciti

Kiniciti is a buy-and-build platform focused on investing in and supporting non-therapeutic service, tools and technology companies that enable innovation and development of cell and gene therapies (CGTs).

CGT is one of the fastest-growing areas in healthcare, providing life-changing or curative therapeutics for previously untreatable conditions. Kiniciti solves the challenges facing CGT-enabling companies that have created outstanding science to support CGT innovators but lack the commercial, operational and strategic expertise to scale fast enough to satisfy market demand and drive down cost. Kiniciti’s partnership model is focused on ensuring that promising companies that support CGT innovation have access to capital, expertise and strategic resources.

Current CEO: Geoff Glass

Headquarters: New York, NY

Investment Year: 2021

Fund: WCAS Fund XIII